Original Article

Newest Oldest Showing 41-60 of 71 results
Original Article / VOLUME 3, ISSUE 2, AUGUST 2021

Predictors of COVID-19 among Healthcare Workers who were Exposed to COVID-19

Çiğdem Erol and others

SARS-CoV-2 is transmitted via the inhalation of infected droplets or through direct contact with contaminated surfaces. Aerosol-generating procedures can also lead to airborne transmission. Healthcare workers (HCWs) are at higher risks for infections than the general (...) Read More

Original Article / VOLUME 3, ISSUE 1, APRIL 2021

The Impact of C Reactive Protein in Prediction of the Outcome in Infective Endocarditis

Serap Şimşek-Yavuz and others

Infective endocarditis (IE), among the most common life-threatening infection, is a serious disease causing substantial morbidity and mortality. Determining at-risk patients and following them up closely with appropriate interventions are necessary to decrease complications and mortality. Treatment response to infective endocarditis is followed up with the combination of relief of symptoms, blood cultures, echocardiographic investigations and laboratory tests. A simple and widely available test Read More

Original Article / VOLUME 3, ISSUE 1, APRIL 2021

The role of Isolation of the Patients on Hospital Admission for Prevention of Nosocomial Infections

Şiran Keske and others

Healthcare-associated infections (HAI) is an increasing global problem all over the world. Multidrug-resistant (MDR) pathogens, including carbapenem-resistant Gram-negative Enterobacterales, Pseudomonas spp. and Acinetobacter spp. have become common causes of HAI, such as central line-associated bloodstream infections (BSIs), catheter-associated urinary tract infections (UTIs), surgical site infections (SSIs) and ventilatory associated pneumonia (VAPs). These infections increase not only mortality but also healthcare Read More

Original Article / VOLUME 3, ISSUE 1, APRIL 2021

Persistent Symptoms After Discharge of COVID-19 Patients

Oğuz Evlice and others

Introduction More than a year has passed since the beginning of the COVID-19 pandemic, and we are learning more about the long-term effects of the disease. While many patients recover completely, some continue to experience fatigue, dyspnea, cough, joint pain, and chest pain for weeks or even months (1).The UK National Institute for Health and […] Read More

Original Article / VOLUME 2, ISSUE 3, DECEMBER 2020

Effectiveness of Surgical Prophylaxis Where the Antibiotic Resistance is High

Mehtap Aydın and others

Surgical site infections (SSI) are defined as infections that occur up to 30 days or one year after surgery in patients with implants, affecting the incision or deep tissue at the surgery site. They account for 20% of all healthcare-associated infections (HAI) in hospitalized patients. Patients with SSI are hospitalised additionally 7-11 days postoperatively. Read More

Original Article / VOLUME 2, ISSUE 2, AUGUST 2020

The Risk of SARS-CoV-2 Infection among Healthcare Workers

Bahar Madran and others

A new coronavirus (SARS-CoV-2) appeared at the end of 2019 in China and spread widely throughout the world. The coronavirus disease 2019 (COVID-19) is a new respiratory disease, and its pandemic has affected more than seven million people all around the world. The first COVID-19 case in Turkey was detected on Read More

Original Article / VOLUME 2, ISSUE 2, AUGUST 2020

Outcomes of COVID-19 Patients Hospitalized in a University Hospital, Turkey

Zeynep Türe and others

In December 2019, Wuhan city, the capital of Hubei province in China, became the center of an outbreak of pneumonia of unknown cause. By Jan 7, 2020, Chinese scientists had isolated a novel coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2; previously known as 2019-nCoV), from these Read More

Original Article / VOLUME 2, ISSUE 2, AUGUST 2020

Antimicrobial Resistance and Molecular Patterns in Community-acquired Complicated Intra-abdominal Infections: A Multicentric Study

Vildan Avkan-Oğuz and others

Complicated intra-abdominal infection (cIAI) is defined as localized or diffuse peritonitis with the involvement of multiple intraperitoneal organs. Source control and appropriate empirical antibiotics are essentials of the treatment. There are few clinical and microbiologic studies regarding cIAI in Turkey. Empiric antibiotics were selected due to diagnoses; community-acquired IAI (CA-IAI) or healthcare-associated IAI. Guidelines published on this topic lack definitive criteria for CA-IAI. Read More

Original Article / VOLUME 2, ISSUE 2, AUGUST 2020

HIV as a Chronic Disease: Are Primary Care Physicians Ready?

Özgür Can Eren and others

In 2019, more than 36 million people were estimated to be harboring HIV, and the epidemic caused 39 million deaths worldwide to date.  New adult infections have been declined by 17% between 2007 and 2017 globally. Meanwhile, the incidence has an Read More

Original Article / VOLUME 2, ISSUE 1, APRIL 2020

Comparison of Coombs Gel Test with ELISA and Standard Tube Agglutination Tests Used in Serological Diagnosis of Brucellosis

Çiğdem Akalan Kuyumcu and others

Brucellosis is a zoonotic infectious disease caused by Gram-negative bacteria of the genus Brucella, which is transmitted from animals to humans by direct and indirect pathways. Brucellosis can be confused with various infectious and non-infectious diseases because of its nonspecific clinical signs and symptoms such as fever, sweating, Read More

Original Article / VOLUME 2, ISSUE 1, APRIL 2020

First Presentation of the Complete Infection Cycle of Visceralizing Leishmania infantum/ donovani Hybrid Strain in Turkey: The Host, Reservoir and Vector

Ahmet Özbilgin and others

Visceral Leishmaniasis (VL) is a widespread infectious disease of the reticuloendothelial system which is mostly caused by Leishmania infantum (L. infantum) and L. donovani in the Old World. The disease is endemic in many parts of the world, and estimated cases of VL have reached 300,000 globally with a high rate of HIV co-infection, and over Read More

Original Article / VOLUME 2, ISSUE 1, APRIL 2020

Do Turkish Gynecologists and Obstetricians recommend pregnant women the influenza vaccine?

İrem Akdemir Kalkan and others

Influenza is a systemic infectious disease. Many groups, including patients with concomitant chronic heart and lung diseases, immunosuppressed individuals, people over 50 years old, and all health staff are considered at-risk groups for influenza. Pregnant women are particularly considered to be at a higher risk. Read More

Original Article / VOLUME 1, ISSUE 3, DECEMBER 2019

The Seroprevalence of Anti-Hepatitis E IgG Antibodies in Blood Donors in The Greater Romagna Area, Italy

Anna Pierro and others

Hepatitis E virus (HEV) represents one of the major cause of acute viral hepatitis worldwide, according to the WHO, one-third of the world population has been exposed to HEV. In Europe, there is extensive evidence indicating that HEV is prevalently transmitted by the ingestion of pork and wild boar raw meat, however, [...] Read More

Original Article / VOLUME 1, ISSUE 3, DECEMBER 2019

Rapid Detection of Difficult-to-Culture Bacterial Pathogens Using Real-time Nanopore Sequencing

Aycan Gündoğdu and others

Infectious diseases are the leading causes of mortality and morbidity worldwide. Current diagnosis of clinically significant infectious agents is based on a variety of laboratory-based tests including microscopy, culture, immunoassays and nucleic acid amplification. The majority of these techniques relies on conventional culture-based profiling […] Read More